ClinicalTrials.Veeva

Menu

Association of Anticholinergic Burden With Onset of Delirium in Older Adults With Alzheimer Dementia:

G

Gulhane Training and Research Hospital

Status

Unknown

Conditions

Alzheimer Disease
Delirium
Anticholinergic Adverse Reaction

Treatments

Drug: Anticholinergic burden

Study type

Observational

Funder types

Other

Identifiers

NCT05055895
2020-383

Details and patient eligibility

About

Drugs with anticholinergic properties are commonly prescribed to older persons despite growing evidence of their significant adverse effects. However, limited data are available concerning their contribution to time of onset of delirium. This study aimed to determine the potential association of higher anticholinergic burden to early-onset of delirium superimposed dementia in the older adult.

Enrollment

450 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 65 years and older and diagnosis or fellow-up of Alzhemier dementia in outpatient clinic.

Exclusion criteria

  • The patients with a history of other than Alzhemier dementia or neurodegenerative disease (epilepsy, multiple sclerosis, Parkinson disease, etc.), terminal illness (malignancy, advanced organ failure) were excluded.

Trial design

450 participants in 2 patient groups

early onset deliryum on dementia
Description:
It was earlier than The median time of onset of delirium superimposed dementia
Treatment:
Drug: Anticholinergic burden
Delirium on dementia (normal)
Description:
It was equal or later than The median time of onset of delirium superimposed dementia
Treatment:
Drug: Anticholinergic burden

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems